Etonogestrel/etinilestradiol Mithra Pharmaceuticals 0,120 mg/0,015 mg na 24 ur vaginalni dostavni sistem স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

etonogestrel/etinilestradiol mithra pharmaceuticals 0,120 mg/0,015 mg na 24 ur vaginalni dostavni sistem

etinilestradiol; etinilestradiol; etonogestrel - vaginalni dostavni sistem - etinilestradiol 2,7 mg / 1 sistem  etinilestradiol2,7 mg / 1 sistem  etonogestrel11,7 mg / 1 sistem; etinilestradiol 2,7 mg / 1 sistem  etonogestrel11,7 mg / 1 sistem; etonogestrel 11,7 mg / 1 sistem - vaginalni obroček s progestogenom in estrogenom

Amversio ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

amversio

serb sa - betaine - homocistinurija - drugi zdravljene bolezni prebavil in presnove izdelki, - amversio is indicated as adjunctive treatment of homocystinuria, involving deficiencies or defects in:•         cystathionine beta-synthase (cbs),•         5,10 methylene tetrahydrofolate reductase (mthfr),•         cobalamin cofactor metabolism (cbl).